Hydrogel coating to prevent infections after hip surgery
Official title: Randomized, Controlled, Monocentric, Feasibility Clinical Investigation to Assess the Safety and Preliminary Clinical Performance of a Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty
Run by Medacta International SA · NCT05679232 · Data updated 2026-11-12
This study is testing whether a special hydrogel coating can help prevent infections after hip surgery for people getting a new hip implant.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 56 (estimated) |
| Sponsor | Medacta International SA Industry-sponsored |
| Locations | 1 site (Vienna) |
| Status | Recruiting |
| Started | December 6, 2022 |
| Main results expected | March 6, 2027 |
| Study ends | December 6, 2027 |
| Registry record updated | October 7, 2026 |
| Trial ID | NCT05679232 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 scheduled for cementless revision hip arthroplasty.
✕Probably not a fit
Patients with contraindications to the hydrogel components or those with active infections may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical investigation evaluates the safety and preliminary effectiveness of MectaShield hydrogel coating in preventing early peri-prosthetic joint infections (PJI) in patients undergoing cementless revision hip arthroplasty. Participants will be randomly assigned to receive either the hydrogel coating or standard care without it. The study aims to ensure that the hydrogel does not interfere with the stability of the implant while monitoring clinical outcomes and any adverse events over a follow-up period of 3 and 12 months. Data will be collected on functional outcomes, infection rates, and overall safety of the treatment.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of infections following hip replacement surgeries, leading to better patient outcomes and lower healthcare costs.
How similar studies have gone: While the use of antibacterial coatings is a promising area, the specific application of MectaShield in this context is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed Consent signed by the subject * Males and females aged over 18 years at time of surgery * Subjects who are scheduled to receive a conical collarless cementless revision hip arthroplasty, with or without revision of the acetabular cup * Subjects willing to comply with the pre- and post-operative evaluation schedule Exclusion Criteria: * Subjects with one or more medical conditions identified as a contraindication defined by the labelling on any implants used in this study * Subjects with immune suppressive treatment for organ transplantation, or known allergy to MectaShield hydrogel constituents (Chitlac, Mannitol, Hydroxypropylmethylcellulose, Sodium phosphate dibasic) * Subjects presenting with progressive local or systemic infection at the time of surgery * Subjects whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems * Subjects affected by concomitant spine, hip, ankle or contralateral knee pathologies that can affect walking capacity * Subjects unable to understand and take action * Subjects undergoing cementless revision hip arthroplasty in emergency interventions
Where it's running
-
Orthopädisches Spital Speising GmbH
Vienna, Austria Recruiting
Study contacts
- Principal investigator: Martin Dominkus, Prof. Dr. — Orthopädisches Spital Speising GmbH
- Study coordinator: Marco Viganó, PhD
- Email: m.vigano@medacta.ch
- Phone: Pho: +41 91 696 60 60
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registry for Physica Total Knee Replacement
This study is testing how well the Physica knee implant works for people getting total knee replacements over the next 10 years.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
Tornier Perform Reversed MonoPost Shoulder Implant: Patient Follow-Up in Real World Care
This study tests how well the Tornier Perform Reversed MonoPost shoulder implant works in adults with shoulder problems over two years by following patients after surgery at multiple centers.
-
Tipmed Shoulder Prosthesis PMCF: safety and outcomes after shoulder replacement
This PMCF study tests the safety and function of the Tipmed shoulder prosthesis in adults undergoing reverse shoulder or hemiarthroplasty in real-world practice.
-
Ultrasound Before Corticosteroid Injection for Arthritis
This trial tests whether applying ultrasound before a corticosteroid joint injection helps improve arthritis symptoms in adults with limb arthritis who need an injection.
-
Ultralow-dose PET scan to detect bone activity with 18F‑NaF
This trial tests whether a new high-sensitivity PET scan using a tiny amount of 18F‑sodium fluoride can produce clear bone images in adults with or without bone disease while cutting radiation exposure by 10–100 times.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.